Clinical trials: Misoprostol
Cervical Ripening, Induction of Labor
Pharmacokinetics and Safety of the 100 Mcg Misoprostol Vaginal Insert (MVI 100)
This study will provide pharmacokinetic data for the MVI 100 (100 mcg) misoprostol vaginal insert when administered to nulliparous women at term gestation requiring cervical ripening and induction of labor.
- Trial name
- Miso-Obs-203 (NCT00528255)
- Testing
- Misoprostol Vaginal Insert (MVI 100)
- Where
- 6 sites in United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- Ferring Pharmaceuticals